Sickle Cell Disease Trial, Recruiting (NCT05099874)

Sickle Cell Disease Trial, Recruiting NCT05099874 Sponsor: Children's National Research Institute Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05099874 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Sickle Cell Disease (SCD)
You are between 8 and 16 years old
You have been receiving monthly blood transfusions regularly for at least 3 months
To move into the active part of the trial, you would need to score above the 75th percentile on specific attention and focus tests given at the start of the study (the trial team will explain and administer these tests)

Who may not be able to join:

You have an estimated IQ score below 70
You have a physical difficulty with movement, vision, or hearing that would prevent you from using a computer
You have a known mental health condition that would make participation unsuitable or that needs to be treated first (confirm with trial site)
You have a history of seizures triggered by flashing lights or visual patterns
You are not able to communicate or work well enough in English to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven J Hardy, Ph.D., Children's National Research Institute

Phone: 202-476-5000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05099874

Sponsor: Children's National Research Institute

Phase: Not Applicable

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 202-476-5000

More information: https://clinicaltrials.gov/study/NCT05099874

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Sickle Cell Disease (SCD)
You are between 8 and 16 years old
You have been receiving monthly blood transfusions regularly for at least 3 months
To move into the active part of the trial, you would need to score above the 75th percentile on specific attention and focus tests given at the start of the study (the trial team will explain and administer these tests)

Who may not be able to join:

You have an estimated IQ score below 70
You have a physical difficulty with movement, vision, or hearing that would prevent you from using a computer
You have a known mental health condition that would make participation unsuitable or that needs to be treated first (confirm with trial site)
You have a history of seizures triggered by flashing lights or visual patterns
You are not able to communicate or work well enough in English to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Children's National Research Institute

Registry

ClinicalTrials.gov

Start date

20 December 2022

Est. completion

1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

EndeavorRx feasibility assessed by patient/family interest; EndeavorRx feasibility assessed by program completion rates; EndeavorRx feasibility assessed by reports of technical ease-of-use and satisfaction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov